Marc Laporta, MD, develops international collaborative ventures  in the area of emergencies and disasters for the Americas.

Monique Séguin is interested in the bereavement process and intervention strategies following suicide.

Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Howard Steiger contributed to the advancement of knowledge regarding causal mechanisms and clinical management of eating disorders.

Martin Lepage uses using functional magnetic resonance imaging (fMRI) to study memory deficits in patients with schizophrenia.

Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

David Bloom treats and ensures follow-up for patients who suffer from schizophrenia and bipolar disorder.

Anne Crocker, PhD, focuses her work on the interface between mental health and the law.